TransCode Therapeutics Announces Publication in Cancer Nanotechnology of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Metastatic Breast CancerBusiness Wire • 09/23/21
TransCode Therapeutics Reports Business Progress and Second Quarter 2021 Financial ResultsBusiness Wire • 08/23/21
TransCode Therapeutics Secures NIH Funding To Support Its Lead Program DevelopmentBenzinga • 08/05/21
TransCode Therapeutics Awarded Funding from National Institutes of Health (NIH) to Support Clinical Evaluation of TTX-MC138Business Wire • 08/05/21
TransCode Therapeutics, Inc. Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters' Over-allotment OptionBusiness Wire • 07/13/21